Hi @jkshares
If you mean "wake up" with respect to movement in the SP, I would probably disagree. Until we have clarity around, firstly, completion of the US trials and, secondly, FDA approval, I can't see the SP moving too far from current. Perhaps we will have a run up (as @vwboy alluded to in his previous post) as we near the expected release dates for those announcements, otherwise I think we are reasonably range bound, and in fact fully priced pending the outcome of those key announcements.
Just my thoughts on an idle Monday morning here in NZ.
Roy
- Forums
- ASX - By Stock
- RAP
- Ann: RAP Licenses Additional Pneumonia Diagnostic from UniQuest
Ann: RAP Licenses Additional Pneumonia Diagnostic from UniQuest, page-93
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online